Fetal congenital anomalies are one of the most important causes of fetal morbidity and mortality in the world. With the advent of ultrasonography it has become much easier to detect congenital anomalies at earlier stages for further evaluation and management. In this study a total number of 1800 patients were selected for study during the period of first July 2021 to 30th September 2022. Congenital anomalies were detected in 47 patients with a prevalence of 2.6%. Patents were divided in to two groups. Group – I had some underlying medical conditions (380 patients) and group-II had no underlying medical conditions (1420 Patients). Prevalence of congenital anomalies were found to be more in group-I patients with significant P value (0.002). Central nervous system anomalies were found to have the highest incidence 42.5%.